Skip to main content

Table 1 Selected characteristics of the 964 participants.

From: Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density

 

All

Mean

 

   Age at screening, y

61.4 (± 4.6)

   Age at menarche, y

13.3 (± 1.4)

   Age at first birth*, y

22.9 (± 3.7)

   Number of children*

2.9 (± 1.3)

   Education, y

9.8 (± 3.4)

   Age at menopause, y

48.6 (± 5.1)

   BMI, kg/m2

27.3 (± 4.8)

Frequency (%)

 

   Ever Oral Contraceptive use

51.1

   Parous

92.6

   Ever postmenopausal hormone therapy use

43.4

   Current postmenopausal hormone therapy use

26.0

   Past postmenopausal hormone therapy use

17.3

   Never postmenopausal hormone therapy use

56.6

   Breast cancer in first degree relative

8.3

Median

 

   Percent mammographic density, %

9.6 (0-69.2)

   Absolute mammographic density, cm2

14.8 (0-155.2)

   Non-dense mammographic area, cm2

147.0 (21.6-448.9)

   IGF1 (ng/ml)

28.7 (2.2-104.6)

   IGFBP3 (ng/ml)

151.2 (52.17-241.5)

  1. *Among parous women only.
  2. Data collected as part of the Tromsø Mammography and Breast Cancer(TMBC) study in Tromsø, Norway in 2001-2002, presented as mean (± standard deviation), frequency (%), and median (range).